RDY:NYSE
Dr Reddy's Laboratories Ltd
13,07 $
arrow_upward
+1,32%(+0,17) 1D
13,07 $
0,00% (0,00)
bedtimePo zaprtju
Zaprto: 16. okt., 16:00:07 GMT -4 · USD
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za RDY …
Odpri
13,00 $
Visoka
13,07 $
Nizka
12,94 $
Tržna kapitalizacija
10,81 mrd.
Povprečni promet
3,19 mio.
Promet
2,79 mio.
Dividenda
0,64 %
Četrtletna dividenda
0,02 $
Prvi trgovalni dan brez upravičenja do dividende
10. jul. 2026
Razmerje med ceno delnice in čistim dobičkom
31,34
52-tedenski najvišji tečaj
15,67 $
52-tedenski najnižji tečaj
11,36 $
Čisti dobiček na delnico
0,42 $
Beta
0,30
Št. izdanih delnic
834,64 mio.
Št. zaposlenih
28 tis.
Odpri
13,00 $
Visoka
13,07 $
Nizka
12,94 $
Tržna kapitalizacija
10,81 mrd.
Povprečni promet
3,19 mio.
Promet
2,79 mio.
Dividenda
0,64 %
Četrtletna dividenda
0,02 $
Prvi trgovalni dan brez upravičenja do dividende
10. jul. 2026
Razmerje med ceno delnice in čistim dobičkom
31,34
52-tedenski najvišji tečaj
15,67 $
52-tedenski najnižji tečaj
11,36 $
Čisti dobiček na delnico
0,42 $
Beta
0,30
Št. izdanih delnic
834,64 mio.
Št. zaposlenih
28 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
MarketBeat
·
pred 2 urama
Dr. Reddy's Laboratories (NYSE:RDY) Stock Rating Raised to "Hold" at Wall Street Zen
CNBC TV18
·
pred 21 urami
Pharma Stocks: Macquarie sees margin pressure in Q2, upgrades Dr Reddy’s and Alkem
ad-hoc-news.de
·
pred 1 dnevom
Dr Reddy reports three FDA observations: what it means for Dr Reddy stock
TipRanks
·
pred 2 dnevoma
Dr. Reddy’s Receives USFDA Form 483 After Pre-Approval Inspection at Visakhapatnam Plant
Profil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Vizitka: Dr Reddy's Laboratories Ltd
Generalni direktorErez Israeli
Št. zaposlenih27,5 tis.
Ustanovljeno1984
SedežHyderabad, Andra Pradeš, Indija
Sektor-
Spletno mestodrreddys.com